Bayer (company)

Bayer (company)
source
Name	Bayer
Type	Publicly traded Aktiengesellschaft
Industry	Pharmaceuticals, Biotechnology, Agrochemicals, Consumer health
Founded	1863
Founder	Friedrich Bayer; Johann Friedrich Weskott
Headquarters	Leverkusen, North Rhine-Westphalia, Germany
Area served	Worldwide
Key people	Werner Baumann; Stefan Oelrich; Klaus Kübler
Products	Pharmaceuticals; Glyphosate-based herbicides; Aspirin descendants; Xarelto; Kogenate; Eylea
Revenue	EUR (varies yearly)
Employees	(approx. global)
Website	bayer.com

Bayer (company) is a multinational chemical and pharmaceutical firm founded in 1863 in Wuppertal and headquartered in Leverkusen. The company grew from dye and chemical manufacturing into a global conglomerate with significant operations in pharmaceuticals, crop science, and consumer health. Bayer has been involved in landmark innovations, high-profile mergers and acquisitions, regulatory engagements with institutions such as the European Commission and the United States Food and Drug Administration, and controversies linked to products like glyphosate-containing herbicides and pharmaceutical recalls.

History

Bayer traces origins to founders Friedrich Bayer and Johann Friedrich Weskott in 1863 in Elberfeld, later part of Wuppertal. Early expansion included synthetic dyes and the development of acetylsalicylic acid derivatives leading to Aspirin. The firm engaged with partners and competitors including IG Farben during the 20th century, was impacted by events such as World War I, World War II, and postwar industrial restructuring overseen by the Allied occupation of Germany. In the postwar era Bayer reconstituted, expanded into pharmaceuticals and agrochemicals, and pursued acquisitions including Miles Laboratories, Schering AG (via Schering-Plough interactions), and later Monsanto which had ties to Bayer CropScience. Corporate decisions involved regulators like the European Commission and national authorities in United States antitrust reviews. Leadership figures across decades—board members, CEOs, and executives—shaped strategy amid technological shifts in biotechnology and genetics research, interactions with universities, and partnerships with institutions such as the Max Planck Society and Helmholtz Association.

Corporate structure and operations

Bayer operates as a publicly traded Aktiengesellschaft listed on exchanges including Frankfurt Stock Exchange and subject to oversight by regulators like the German Corporate Governance Code. Corporate divisions include pharmaceuticals, consumer health, crop science, and previously material science units. Headquarters in Leverkusen coordinate global regional hubs across North America, Latin America, Asia-Pacific, and Africa. The company manages supply chains involving chemical plants, biomanufacturing facilities, and research centers collaborating with entities such as BASF, Dow Chemical Company, Syngenta, and academic partners like Heidelberg University. Governance structures involve a supervisory board, an executive board, investor relations engaging institutional shareholders like BlackRock and Vanguard Group, and engagement with rating agencies such as Moody's Investors Service and Standard & Poor's.

Products and research divisions

Bayer’s pharmaceutical portfolio includes anticoagulants like Xarelto, ophthalmology products such as Eylea (co-developed with Regeneron Pharmaceuticals), hematology treatments including Kogenate collaborations, and over-the-counter brands. The crop science division, expanded significantly after acquiring Monsanto, markets herbicides, seeds, and biotech traits including glyphosate-tolerant crops, interacting with competitors Bayer CropScience legacy firms like Monsanto Company and Syngenta AG. Research units encompass drug discovery, clinical development, agricultural biotechnology, and digital farming initiatives partnering with technology firms like Microsoft, IBM, and startups incubated by venture investors. R&D collaborations include projects with European Molecular Biology Laboratory, Karolinska Institutet, and consortia funded by the Bill & Melinda Gates Foundation. Clinical trials register with agencies such as the European Medicines Agency and ClinicalTrials.gov; intellectual property is managed through portfolios of patents filed at the European Patent Office and the United States Patent and Trademark Office.

Legal issues and controversies

Bayer has faced litigation involving products, regulatory disputes, and compliance matters. High-profile cases include lawsuits over glyphosate-based herbicides initiated in jurisdictions like United States District Court for the Northern District of California and state courts, involving plaintiffs represented by law firms such as Keller Rohrback LLP and Baum Hedlund Aristei & Goldman. Pharmaceutical legal matters have involved liability claims tied to drugs subject to regulatory scrutiny by the European Medicines Agency and the Food and Drug Administration. Antitrust and merger approvals for the Monsanto acquisition required concessions reviewed by the European Commission and the United States Department of Justice. Environmental and occupational claims intersected with agencies such as Environmental Protection Agency and national ministries. Corporate probity issues invoked audits by firms like the Big Four accounting firms and shareholder actions before courts such as the Bundesgerichtshof.

Financial performance and corporate governance

Financial metrics—annual revenue, operating income, and net profit—are reported in filings to the Deutsche Börse and regulatory disclosures to entities such as the Federal Financial Supervisory Authority (BaFin). Investor relations engage analysts from banks like Deutsche Bank, Goldman Sachs, and J.P. Morgan, and institutional investors including BlackRock and Allianz Global Investors. Governance reforms have responded to shareholder resolutions, proxy votes, and stewardship codes influenced by groups like the Institutional Shareholder Services and Glass Lewis. Creditworthiness is assessed by Moody's, S&P Global Ratings, and Fitch Ratings. Strategic finance events have included divestitures, spin-offs, and capital allocation decisions influenced by macroeconomic conditions in markets such as China, Brazil, and the European Union.

Sustainability and corporate responsibility

Bayer publishes sustainability reports aligning with frameworks from the United Nations Global Compact, Sustainable Development Goals, and reporting standards of the Global Reporting Initiative. Environmental initiatives address emissions, water use, and pesticide stewardship in coordination with regulators like the European Chemicals Agency and programs with NGOs such as WWF and Greenpeace. Public health collaborations involve partnerships with the World Health Organization and humanitarian agencies. Corporate philanthropy and foundations support research at institutions including Charité – Universitätsmedizin Berlin and outreach through partnerships with the Bill & Melinda Gates Foundation. CSR efforts respond to stakeholder groups including consumer advocates, farmer associations, and investor networks focused on environmental, social, and governance criteria such as PRI signatories.

Category:Multinational companies headquartered in Germany Category:Chemical companies of Germany Category:Pharmaceutical companies of Germany